CCEL

Cryo-Cell International, Inc. AMEX Listed Apr 4, 1994

Healthcare ·Medical - Care Facilities ·US · cryo-cell.com

$3.45

Mkt Cap $27.8M

52w Low $2.72 20.1% of range 52w High $6.35

50d MA $3.40 200d MA $3.97

P/E (TTM) -11.7x

EV/EBITDA 72.8x

P/B —

Debt/Equity -0.2x

ROE 14.5%

P/FCF 6.1x

RSI (14) —

ATR (14) —

Beta 0.63

50d MA $3.40

200d MA $3.97

Avg Volume 14.1K

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

SIC Code

8090

CIK (SEC)

862692

Phone

813 749 2100

700 Brooker Creek Boulevard · Oldsmar, FL 34677 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 14, 2026	AMC	-0.02	0.01	+150.0%	3.67	-7.1%	+1.1%	-2.4%	-5.0%	+3.5%	+0.0%	—
Feb 27, 2026	AMC	-0.09	-0.47	-422.2%	3.40	-4.4%	-3.5%	+0.3%	-0.3%	+0.0%	-1.2%	—
Oct 15, 2025	AMC	—	0.09	—	4.55	-4.4%	-1.1%	+1.1%	-0.7%	-3.8%	+2.1%	—
Jul 15, 2025	AMC	-0.03	0.04	+233.3%	4.91	+2.4%	+0.0%	-1.2%	-0.6%	-2.5%	+12.6%	—
Feb 28, 2025	AMC	0.01	-0.23	-2400.0%	7.90	+0.0%	-14.9%	-1.8%	+7.9%	-1.3%	+2.0%	—
Feb 26, 2025	AMC	0.01	0.26	+2500.0%	7.59	-1.1%	+5.4%	-1.2%	-14.9%	-1.8%	+7.9%	—
Oct 15, 2024	AMC	0.02	0.13	+550.0%	5.84	+7.0%	+7.0%	-1.0%	+2.4%	-1.9%	-0.3%	—
Jul 15, 2024	AMC	0.04	0.08	+100.0%	7.12	+6.7%	+0.8%	+3.5%	-0.9%	-2.6%	+3.2%	—
Apr 15, 2024	AMC	-0.00	0.07	+1816.2%	7.08	-0.8%	-5.4%	+0.7%	+9.2%	+1.8%	+5.6%	—
Feb 28, 2024	AMC	-0.07	0.26	+471.4%	5.05	-1.6%	+3.0%	-5.6%	+8.4%	+6.2%	-2.5%	—
Oct 12, 2023	AMC	-0.06	0.08	+233.3%	5.04	+0.8%	-2.2%	-2.2%	+0.0%	-3.9%	+0.4%	—
Jul 14, 2023	AMC	-0.08	0.03	+137.5%	6.63	-0.3%	-9.5%	+7.5%	-2.2%	-2.5%	-2.1%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Oct 20	Maxim Group	Downgrade	Buy → Hold	—	$4.55	$4.61	+1.3%	-0.7%	-3.8%	+2.1%	+0.0%	-2.0%
Mar 4	Maxim Group	Maintains	Buy → Buy	—	$6.72	$6.73	+0.1%	-1.8%	+7.9%	-1.3%	+2.0%	-9.3%
Aug 29	Maxim Group	Maintains	Buy → Buy	—	$6.30	$6.26	-0.6%	+6.3%	+8.2%	+1.7%	-4.9%	-3.6%

Data updated apr 25, 2026 12:16am · Source: massive.com